Nuravax Inc., a clinical-stage biopharmaceutical company developing active immunotherapies for neurodegenerative diseases, announced today that two oral presentations—the Phase 1 clinical results and ...

The Apple Watch Series 11 is set to debut in September 2025, alongside the eagerly awaited iPhone 17. With a starting price ...